in vitro evaluation of swine-derived lactobacillus reuteri: Probiotic properties and effects on intestinal porcine epithelial cells challenged with enterotoxigenic Escherichia coli K88

Journal of Microbiology and Biotechnology

Volumn 26, Issue 6, 2016, Pages 1018-1025

  Wang, Zhilin ^a   Wang, Li ^a   Chen, Zhuang ^a   Ma, Xianyong ^a   Yang, Xuefen ^a   Zhang, Jian ^a   Jiang, Zongyong ^a  

^a INSTITUTE OF ANIMAL SCIENCE   (China)

Author keywords

Enterotoxigenic Escherichia coli; In vitro evaluation; Lactobacillus reuteri; Probiotic properties

Indexed keywords

ANTIBIOTIC AGENT; CYTOKINE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; INTERLEUKIN 10; INTERLEUKIN 6; PROBIOTIC AGENT; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CELL ADHESION; DRUG EFFECT; DRUG SCREENING; ENTEROTOXIGENIC ESCHERICHIA COLI; FECES; IMMUNOLOCALIZATION; IN VITRO STUDY; INFLAMMATION; INTESTINE EPITHELIUM CELL; LACTIC ACID BACTERIUM; LACTOBACILLUS REUTERI; MONOLAYER CULTURE; NONHUMAN; NUCLEOTIDE SEQUENCE; PIG; PROTEIN EXPRESSION; STRESS; ANIMAL; ANTIBIOSIS; BACTERIUM ADHERENCE; BILE; CLASSIFICATION; CYTOLOGY; EPITHELIUM CELL; EVALUATION STUDY; GENETICS; INTESTINE; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; LACTOBACILLUS; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; TIGHT JUNCTION; ULTRASTRUCTURE;

ANIMALS; ANTIBIOSIS; BACTERIAL ADHESION; BILE; ENTEROTOXIGENIC ESCHERICHIA COLI; EPITHELIAL CELLS; FECES; IN VITRO TECHNIQUES; INTERLEUKIN-10; INTERLEUKIN-6; INTESTINAL MUCOSA; INTESTINES; LACTOBACILLUS; LACTOBACILLUS REUTERI; PROBIOTICS; SWINE; TIGHT JUNCTIONS;

EID: 84975260070     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.1510.10089     Document Type: Article

References (32)

1. Araya M, Morelli L, Reid G, Sanders M, Stanton C, Pineiro M, Ben Embarek P. 2002. Guidelines for the evaluation of probiotics in food. Report of a Joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. London, Ontario, Canada.
2. Cario E, Gerken G, Podolsky DK. 2004. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C. Gastroenterology 127: 224-238.
3. Casas IA, Dobrogosz WJ. 2000. Validation of the probiotic concept: Lactobacillus reuteri confers broad-spectrum protection against disease in humans and animals. Microbial Ecol. Health Dis. 12: 247-285.
4. De Angelis M, Siragusa S, Berloco M, Caputo L, Settanni L, Alfonsi G, et al. 2006. Selection of potential probiotic lactobacilli from pig feces to be used as additives in pelleted feeding. Res. Microbiol. 157: 792-801.
5. Dibner J, Richards J. 2005. Antibiotic growth promoters in agriculture: history and mode of action. Poultry Sci. 84: 634-643.
6. Fairbrother JM, Nadeau É, Gyles CL. 2005. Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies. Anim. Health Res. Rev. 6: 17-39.
7. Foligne B, Nutten S, Grangette C, Dennin V, Goudercourt D, Poiret S, et al. 2007. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J. Gastroenterol. 13: 236-243.
8. Frese SA, Benson AK, Tannock GW, Loach DM, Kim J, Zhang M, et al. 2011. The evolution of host specialization in the vertebrate gut symbiont Lactobacillus reuteri. PLoS Genet. 7: e1001314.
9. Gaggìa F, Mattarelli P, Biavati B. 2010. Probiotics and prebiotics in animal feeding for safe food production. Int. J. Food Microbiol. 141: S15-S28.
10. Heller KJ. 2001. Probiotic bacteria in fermented foods: product characteristics and starter organisms. Am. J. Clin. Nutr. 73: 374s-379s.
11. Juntunen M, Kirjavainen P, Ouwehand A, Salminen S, Isolauri E. 2001. Adherence of probiotic bacteria to human intestinal mucus in healthy infants and during rotavirus infection. Clin. Diagn. Lab. Immunol. 8: 293-296.
12. Kaushik JK, Kumar A, Duary RK, Mohanty AK, Grover S, Batish VK. 2009. Functional and probiotic attributes of an indigenous isolate of Lactobacillus plantarum. PLoS One 4: e8099.
13. Kim HB, Isaacson RE. 2015. The pig gut microbial diversity: understanding the pig gut microbial ecology through the next-generation high-throughput sequencing. Vet. Microbiol. 177: 242-251.
14. Koh SY, George S, Brözel V, Moxley R, Francis D, Kaushik RS. 2008. Porcine intestinal epithelial cell lines as a new in vitro model for studying adherence and pathogenesis of enterotoxigenic Escherichia coli. Vet. Microbiol. 130: 191-197.
15. Kotzamanidis C, Kourelis A, Litopoulou-Tzanetaki E, Tzanetakis N, Yiangou M. 2010. Evaluation of adhesion capacity, cell surface traits and immunomodulatory activity of presumptive probiotic Lactobacillus strains. Int. J. Food Microbiol. 140: 154-163.
16. Kowapradit J, Opanasopit P, Ngawhiranpat T, Apirakaramwong A, Rojanarata T, Ruktanonchai U, Sajomsang W. 2008. Methylated N-(4-N, N-dimethylaminobenzyl) chitosan, a novel chitosan derivative, enhances paracellular permeability across intestinal epithelial cells (Caco-2). AAPS PharmSciTech 9: 1143-1152.
17. Lähteinen T, Malinen E, Koort JM, Mertaniemi-Hannus U, Hankimo T, Karikoski N, et al. 2010. Probiotic properties of Lactobacillus isolates originating from porcine intestine and feces. Anaerobe 16: 293-300.
18. Lebeer S, Vanderleyden J, De Keersmaecker SC. 2010. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat. Rev. Microbiol. 8: 171-184.
19. Lee DY, Seo Y-S, Rayamajhi N, Kang ML, Lee SI, Yoo HS. 2009. Isolation, characterization, and evaluation of wild isolates of Lactobacillus reuteri from pig feces. J. Microbiol. 47: 663-672.
20. Lee J, Yun HS, Cho KW, Oh S, Kim SH, Chun T, et al. 2011. Evaluation of probiotic characteristics of newly isolated Lactobacillus spp.: immune modulation and longevity. Int. J. Food Microbiol. 148: 80-86.
21. Meurens F, Berri M, Auray G, Melo S, Levast B, Virlogeux-Payant I, et al. 2009. Early immune response following Salmonella enterica subspecies enterica serovar Typhimurium infection in porcine jejunal gut loops. Vet. Res. 40: 1.
22. Oh PL, Benson AK, Peterson DA, Patil PB, Moriyama EN, Roos S, Walter J. 2010. Diversification of the gut symbiont Lactobacillus reuteri as a result of host-driven evolution. ISME J. 4: 377-387.
23. Roselli M, Finamore A, Britti MS, Konstantinov SR, Smidt H, de Vos WM, Mengheri E. 2007. The novel porcine Lactobacillus sobrius strain protects intestinal cells from enterotoxigenic Escherichia coli K88 infection and prevents membrane barrier damage. J. Nutr. 137: 2709-2716.
24. Saarela M, Mogensen G, Fondén R, Mättö J, Mattila-Sandholm T. 2000. Probiotic bacteria: safety, functional and technological properties. J. Biotechnol. 84: 197-215.
25. Seo BJ, Mun MR, Kim C-J, Lee I, Chang Y-H, Park Y-H. 2010. Bile tolerant Lactobacillus reuteri isolated from pig feces inhibits enteric bacterial pathogens and porcine rotavirus. Vet. Res. Commun. 34: 323-333.
26. Talarico T, Casas I, Chung TC, Dobrogosz W. 1988. Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteri. Antimicrob. Agents Chemother. 32: 1854-1858.
27. Tsukita S, Furuse M, Itoh M. 2001. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2: 285-293.
28. Tuomola EM, Ouwehand AC, Salminen SJ. 1999. The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. FEMS Immunol. Med. Microbiol. 26: 137-142.
29. Vollenweider S, Lacroix C. 2004. 3-Hydroxypropionaldehyde: applications and perspectives of biotechnological production. Appl. Microbiol. Biotechnol. 64: 16-27.
30. Walter J, Britton RA, Roos S. 2011. Host-microbial symbiosis in the vertebrate gastrointestinal tract and the Lactobacillus reuteri paradigm. Proc. Natl. Acad. Sci. USA 108: 4645-4652.
31. Yu LC, Flynn AN, Turner JR, Buret AG. 2005. SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS-induced apoptosis and barrier defects: a novel cellular rescue mechanism? FASEB J. 19: 1822-1835.
32. Zanello G, Berri M, Dupont J, Sizaret P-Y, D’Inca R, Salmon H, Meurens F. 2011. Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells. PLoS One 6: e18573.